Table 4 Multivariate analysis of prognostic factors by Cox proportional hazard model: local control and distant metastases-free survival

Age

0,98 (95% CI, 0.94–1.01)

0.234

0.99 (95% CI, 0.95–1.03)

0.726

Stage

1.20 (95% CI, 0.47–3.07)

0.770

0.90 (95% CI, 0.30–2.68)

0.856

L/node size by CT

1.67 (95% CI, 1.03–2.70)

0.038

1.79 (95% CI, 0.97–3.31)

0.063

Cervix size by CT

0.87 (95% CI, 0.44–1.72)

0.693

0.82 (95% CI, 0.34–1.98)

0.656

Hb blood level

0.36 (95% CI, 0.16–0.80)

0.013

0.75 (95% CI, 0.28–1.97)

0.555

Dose at point A

0.34 (95% CI, 0.14–0.85)

0.021

0.73 (95% CI, 0.19–2.74)

0.642

Dose at point B

1.71 (95% CI, 0.60–4.88)

0.314

1.68 (95% CI, 0.37–7.51)

0.500

Duration of treatment

1.89 (95% CI, 1.05–3.40)

0.033

1.95 (95% CI, 0.90–4.23)

0.090